Huynh, M.D. et al. 2026. EVALUATION OF TREATMENT OUTCOMES OF STAGE IIIB–IV NON- SMALL CELL LUNG CANCER WITH EGFR MUTATIONS USING FIRST-GENERATION TYROSINE KINASE INHIBITORS AT CAN THO CITY IN 2020 - 2023. Cantho Journal of Medicine and Pharmacy. 94 (Jan. 2026), 151–157. DOI:https://doi.org/10.58490/ctjump.2026i94.4270.